The Biomedical Advanced Research and Development Authority (BARDA) is searching for new ways to deliver vaccines, and to do so, it has found four partners in research: Esperovax, Inc., the University of Connecticut, Vaxess Technologie, and Verndari, Inc.
The two options being investigated... Read More »
AbbVie is teaming up with Harvard University on a $30 million research alliance to study and develop novel therapies against emergent viral infections.
The focus of the research, which will take place at Harvard Medical School (HMS), is on viral infections caused by coronaviruses and other... Read More »
U.S. Sen. Dick Durbin (D-IL) discussed the research and approval process for COVID-19 vaccine candidates with General Gustave Perna, chief operating officer for Operation Warp Speed, a public-private partnership designed to accelerate the development of COVID-19 vaccines and treatments,
Durbin... Read More »
U.S. Citizenship and Immigration Services (USCIS) officials said spending cuts and increased incoming revenue and receipts has resulted in averting an administrative furlough of more than 13,000 employees.
“Our workforce is the backbone of every USCIS accomplishment. Their resilience and... Read More »
U.S. Rep. Doug LaMalfa (R-CA) said lack of planning, personnel, and equipment has led to extreme California wildfire damage and has invited federal officials to the state to aid with solutions.
LaMalfa said he has extended an invitation to Vice President Mike Pence, Secretary of Agriculture... Read More »
Changes to the requirements for emergency use authorization (EUA) of convalescent plasma as a COVID-19 treatment by the U.S. Food and Drug Administration (FDA) has raised new barriers for hospitals, and a new line of questions from U.S. Reps. Debbie Dingell (D-MI) and Fred Upton (R-MI).
In a... Read More »
A phase 1 clinical trial for AZD7442, a combination monoclonal antibody treatment for COVID-19 licensed by AstraZeneca, began this week for 48 healthy participants in the United Kingdom.
Throughout the study, researchers will assess the safety, tolerability, and pharmacokinetics of the... Read More »
Bavarian Nordic released the results from its Phase 3 study of the freeze-dried formulation of its MVA-BN smallpox vaccine.
The FDA approved the liquid-frozen formulation of the vaccine in September 2019 under the name JYNNEOS. The prior Phase 2 study has shown bioequivalence between the... Read More »
U.S. Reps. Frank Pallone, Jr., (D-NJ), Anna G. Eshoo (D-CA) and Diana DeGette (D-CO) are calling on the Food and Drug Administration (FDA) commissioner to ensure that sound science and the protection of public health alone drive FDA’s COVID-19 vaccine approval process.
“Any political... Read More »
Cleveland, Ohio-based University Hospitals will serve as one of 120 global clinical investigational sites to test Pfizer and BioNTech's COVID-19 vaccine.
The clinical trial would be initiated at UH Cleveland Medical Center. Dr. Robert Salata, chairman of the Department of Medicine at UH... Read More »
Cybersecurity and Infrastructure Security Agency (CISA) officials said the agency’s fifth generation (5G) technology strategy seeks to advance the development and deployment of a secure and resilient infrastructure.
“The promise of 5G is undeniable, but with 5G technology posed to underpin a... Read More »
According to the World Health Organization (WHO) and Gavi, the Vaccine Alliance, the global COVAX initiative can now count 172 national economies and nine potential COVID-19 vaccines under its banner, seven of which have entered clinical trials.
The goal of the COVAX facility is to bring the... Read More »